At the endpoint of mice model, data confirmed that both tumor weight and the ratio of tumor/body weight were less in JAC1 treated group than in solvent control group; and JAC1 indicated a tumor inhibition rate of 37.4% to TNBC (Fig. 4B–D). This evidence concerns the gene HSCB and neoplasm.